{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T08:55:30Z","timestamp":1790412930213,"version":"4.1.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"40","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1097\/md.0000000000004908","type":"journal-article","created":{"date-parts":[[2016,10,6]],"date-time":"2016-10-06T13:23:24Z","timestamp":1475760204000},"page":"e4908","source":"Crossref","is-referenced-by-count":34,"title":["Persistence to antihypertensive drug classes"],"prefix":"10.1097","volume":"95","author":[{"given":"Miriam","family":"Qvarnstr\u00f6m","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helle","family":"Kieler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Hasselstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina Bengtsson","family":"Bostr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Manhem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Hjerpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Wettermark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-30-20210309","doi-asserted-by":"crossref","first-page":"b1665","DOI":"10.1136\/bmj.b1665","article-title":"Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies","volume":"338","author":"Law","year":"2009","journal-title":"BMJ"},{"key":"R2-30-20210309","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1161\/HYPERTENSIONAHA.108.125617","article-title":"Continued improvement in hypertension management in England: results from the Health Survey for England 2006","volume":"53","author":"Falaschetti","year":"2009","journal-title":"Hypertension"},{"key":"R3-30-20210309","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1001\/jama.2010.650","article-title":"US trends in prevalence, awareness, treatment, and control of hypertension, 1988\u20132008","volume":"303","author":"Egan","year":"2010","journal-title":"JAMA"},{"key":"R4-30-20210309","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/ajh\/hpv067","article-title":"Trends in antihypertensive medication use and blood pressure control among adults with hypertension in Germany","volume":"29","author":"Sarganas","year":"2016","journal-title":"Am J Hypertens"},{"key":"R5-30-20210309","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1524-4733.2007.00213.x","article-title":"Medication compliance and persistence: terminology and definitions","volume":"11","author":"Cramer","year":"2008","journal-title":"Value Health"},{"key":"R7-30-20210309","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1097\/01.hjh.0000226211.95936.f5","article-title":"Discontinuation of antihypertensive drugs among newly diagnosed hypertensive patients in UK general practice","volume":"24","author":"Burke","year":"2006","journal-title":"J Hypertens"},{"key":"R8-30-20210309","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/HJH.0b013e3282f4edd7","article-title":"Discontinuation of and changes in drug therapy for hypertension among newly-treated patients: a population-based study in Italy","volume":"26","author":"Corrao","year":"2008","journal-title":"J Hypertens"},{"key":"R9-30-20210309","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.amjmed.2009.08.008","article-title":"Antihypertensive drug persistence and compliance among newly treated elderly hypertensives in Ontario","volume":"123","author":"Friedman","year":"2010","journal-title":"Am J Med"},{"key":"R10-30-20210309","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s00228-007-0340-2","article-title":"Persistence with antihypertensive treatments: results of a 3-year follow-up cohort study","volume":"63","author":"Hasford","year":"2007","journal-title":"Eur J Clin Pharmacol"},{"key":"R11-30-20210309","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1097\/01.hjh.0000186832.41125.8a","article-title":"Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care","volume":"23","author":"Mazzaglia","year":"2005","journal-title":"J Hypertens"},{"key":"R12-30-20210309","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1524-6175.2007.07194.x","article-title":"Effects of initial antihypertensive drug class on patient persistence and compliance in a usual-care setting in the United States","volume":"9","author":"Patel","year":"2007","journal-title":"J Clin Hypertens (Greenwich"},{"key":"R13-30-20210309","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1097\/HJH.0b013e32832d4692","article-title":"Management of antihypertensive drugs in three European countries","volume":"27","author":"Nicotra","year":"2009","journal-title":"J Hypertens"},{"key":"R14-30-20210309","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1007\/s00228-013-1555-z","article-title":"Persistence to antihypertensive drug treatment in Swedish primary healthcare","volume":"69","author":"Qvarnstr\u00f6m","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"R15-30-20210309","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3109\/08037051.2013.814829","article-title":"The Swedish Primary Care Cardiovascular Database (SPCCD): 74,751 hypertensive primary care patients","volume":"23","author":"Hasselstr\u00f6m","year":"2014","journal-title":"Blood Press"},{"key":"R17-30-20210309","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.healthpol.2009.09.014","article-title":"Initial effects of a reimbursement restriction to improve the cost-effectiveness of antihypertensive treatment","volume":"94","author":"Wettermark","year":"2010","journal-title":"Health Policy"},{"key":"R18-30-20210309","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/pds.1294","article-title":"The new Swedish Prescribed Drug Register\u2014opportunities for pharmacoepidemiological research and experience from the first six months","volume":"16","author":"Wettermark","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R19-30-20210309","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00228-013-1607-4","article-title":"Persistence of antihypertensive drug use in German primary care: a follow-up study based on pharmacy claims data","volume":"70","author":"Grimmsmann","year":"2014","journal-title":"Eur J Clin Pharmacol"},{"key":"R20-30-20210309","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1161\/CIRCULATIONAHA.110.983874","article-title":"Meta-analysis: impact of drug class on adherence to antihypertensives","volume":"123","author":"Kronish","year":"2011","journal-title":"Circulation"},{"key":"R21-30-20210309","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/sj.jhh.1001873","article-title":"Persistence and discontinuation patterns of antihypertensive therapy among newly treated patients: a population-based study","volume":"19","author":"Bourgault","year":"2005","journal-title":"J Hum Hypertens"},{"key":"R22-30-20210309","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.cjca.2014.03.017","article-title":"Antihypertensive drug prescribing and persistence among new elderly users: implications for persistence improvement interventions","volume":"30","author":"Tu","year":"2014","journal-title":"Can J Cardiol"},{"key":"R23-30-20210309","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1471-2296-9-61","article-title":"Improved persistence and adherence to diuretic fixed-dose combination therapy compared to diuretic monotherapy","volume":"9","author":"Patel","year":"2008","journal-title":"BMC Fam Pract"},{"key":"R24-30-20210309","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1097\/HJH.0000000000000222","article-title":"Factors involved in the discontinuation of antihypertensive drug therapy: an analysis from real life data","volume":"32","author":"Mancia","year":"2014","journal-title":"J Hypertens"},{"key":"R25-30-20210309","doi-asserted-by":"crossref","first-page":"224","DOI":"10.5694\/j.1326-5377.2008.tb01589.x","article-title":"Persistence with antihypertensive medication: Australia-wide experience, 2004\u20132006","volume":"188","author":"Simons","year":"2008","journal-title":"Med J Aust"},{"key":"R26-30-20210309","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1089\/jwh.2011.2876","article-title":"Gender differences in utilization of preventive care services in the United States","volume":"21","author":"Vaidya","year":"2012","journal-title":"J Womens Health (Larchmt"},{"key":"R27-30-20210309","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/jhh.2008.84","article-title":"Do socioeconomic disparities affect accessing and keeping antihypertensive drug therapy? Evidence from an Italian population-based study","volume":"23","author":"Corrao","year":"2009","journal-title":"J Hum Hypertens"},{"key":"R28-30-20210309","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1742-1241.2009.02290.x","article-title":"Are men shortchanged on health? Perspective on health care utilization and health risk behavior in men and women in the United States","volume":"64","author":"Pinkhasov","year":"2010","journal-title":"Int J Clin Pract"},{"key":"R29-30-20210309","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/00004872-199715110-00003","article-title":"Sex differences in awareness and control of hypertension in France","volume":"15","author":"Marques-Vidal","year":"1997","journal-title":"J Hypertens"},{"key":"R30-30-20210309","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jash.2014.08.015","article-title":"Gender differences in antihypertensive drug treatment: results from the Swedish Primary Care Cardiovascular Database (SPCCD)","volume":"8","author":"Ljungman","year":"2014","journal-title":"J Am Soc Hypertens"},{"key":"R31-30-20210309","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s00228-008-0495-5","article-title":"Utilisation of angiotensin receptor blockers in Sweden: combining survey and register data to study adherence to prescribing guidelines","volume":"64","author":"Frisk","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"key":"R32-30-20210309","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/jhh.2010.86","article-title":"Antihypertensive treatment and control in a large primary care population of 21167 patients","volume":"25","author":"Qvarnstr\u00f6m","year":"2011","journal-title":"J Hum Hypertens"},{"key":"R33-30-20210309","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/pds.1635","article-title":"Education and drug use in Sweden\u2014a nationwide register-based study","volume":"17","author":"Weitoft","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R34-30-20210309","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3109\/02813432.2012.735552","article-title":"Increased registration of hypertension and cancer diagnoses after the introduction of a new reimbursement system","volume":"30","author":"Hjerpe","year":"2012","journal-title":"Scand J Prim Health Care"},{"key":"R35-30-20210309","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3109\/08037051.2015.1121706","article-title":"Adherence to medication and drug monitoring in apparent treatment-resistant hypertension","volume":"25","author":"Esk\u00e5s","year":"2016","journal-title":"Blood Press"},{"key":"R36-30-20210309","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3389\/fphar.2014.00219","article-title":"Different initiatives across Europe to enhance losartan utilization post generics: impact and implications","volume":"5","author":"Moon","year":"2014","journal-title":"Front Pharmacol"},{"key":"R37-30-20210309","doi-asserted-by":"crossref","first-page":"231S","DOI":"10.1016\/S0895-7061(01)02132-X","article-title":"Issues in hypertension: drug tolerability and special populations","volume":"14","author":"Gavras","year":"2001","journal-title":"Am J Hypertens"},{"key":"R38-30-20210309","first-page":"1093","article-title":"Short and long-term clinical tolerance of hypertensive treatment during the HOT study (Hypertension Optimal Treatment)","volume":"89","author":"Mallion","year":"1996","journal-title":"Arch Mal Coeur Vaiss"},{"key":"R39-30-20210309","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1097\/HJH.0b013e32830dd0c6","article-title":"Sexual dysfunction: the \u201cprima ballerina\u201d of hypertension-related quality-of-life complications","volume":"26","author":"Manolis","year":"2008","journal-title":"J Hypertens"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000004908","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:33:52Z","timestamp":1620959632000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201610040-00030"}},"subtitle":["A cohort study using the Swedish Primary Care Cardiovascular Database (SPCCD)"],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":37,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000004908","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]}}}